| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |